Bleeding patterns in peri and postmenopausal women taking a continuous combined regimen of estradiol with norethisterone acetate or a conventional sequential regimen of conjugated equine estrogens with medrogestone

Maturitas

Volumn 43, Issue 4, 2002, Pages 265-275

  Von Holst, Thomas ^a   Lang, Eva ^b   Winkler, Ulrich ^c   Keil, Dieter ^d  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b Novo Nordisk Pharma GmbH   (Germany)

^c Friedrich Ebert Krankenhaus   (Germany)

^d NONE   (Germany)

Author keywords

Bleeding; Estradiol; Low dose continuous combined hormone replacement therapy; Norethisterone acetate; Perimenopausal women

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; KILOGEST; MEDROGESTONE; NORETHISTERONE ACETATE;

ADULT; AGED; AMENORRHEA; ARTICLE; BLEEDING; CLIMACTERIUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENOPAUSE; POSTMENOPAUSE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SPOTTING; TREATMENT OUTCOME;

EQUIDAE; NETA;

EID: 0037058837     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(02)00203-7     Document Type: Article

References (20)

1. Stadberg E., Mattsson L.A., Uvebrant M. 17β-estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy. Maturitas. 23:1996;31-39.
2. Loh F.H., Chen L.H., Yu S.L., Jorgensen L.N. The efficacy of two dosages of a continuous combined hormone replacement regimen. Maturitas. 41:2002;123-131.
3. Dören M., Rübig A., Coelingh Bennink H.J.T., Holzgreve W. Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy. Menopause. 6:1999;299-306.
4. Archer D.F., Dorin M.H., Heine W., Nanavati N., Arce J.C. Uterine bleeding in postmenopausal women on continuous therapy with estradiol and norethindrone acetate. Obstet. Gynecol. 94:1999;323-329.
5. Johnson J.V., Davidson M., Archer D., Bachmann G. Postmenopausal uterine bleeding profiles with two forms of continuous combined hormone replacement therapy. Menopause. 9:2002;16-22.
6. Cano A. Compliance to hormone replacement therapy in menopausal women controlled in a third level academic centre. Maturitas. 20:1995;91-99.
7. Hammond C.B. Women's concerns with hormone replacement therapy - compliance issues. Fertil. Steril. 62:(Suppl 2):1994;S157-S160.
8. Stumpf P.G., Trolice M.P. Compliance problems with hormone replacement therapy. Obstet. Gynecol. Clin. N. Am. 21:1994;219-221.
9. Schneider HPG, Hauser GA. The menopause rating scale (MRS II) - Clusters of menopausal symptoms. Maturitas 1996; 273, Supplement: 8th International Congress on the Menopause, 3-7 November, 1996, Sydney, Australia.
10. Hauser G.A., Huber I.C., Keller P.J., Lauritzen C., Schneider H.P.G. Evaluation der klimakterischen Beschwerden (Menopause Rating Scale (MRS)). Zentralbl Gynäkol. 116:1994;16-23.
11. Hunter M., Battersby R., Whitehead M. Relationship between psychological symptoms, somatic complaints and menopausal status. Maturitas. 8:1986;217-228.
12. Wiklund I., Karlberg J., Lindgren R., Sandin K., Mattsson L.Å. A swedish version of the women's health questionnaire. Acta. Obstet. Gynecol. Scand. 72:1993;648-655.
13. Belsey E.M., Farley T.M. The analysis of menstrual bleeding pattern: a review. Contraception. 38:1988;129-156.
14. Dören M. Hormonal replacement regimens and bleeding. Maturitas. 34:(Suppl 1):2000;S17-S23.
15. Archer D.F., Pickar J.H., Bottiglioni F. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Obstet. Gynecol. 83:1994;686-692.
16. Ettinger B., Pressman A., Silver P. Effect of age on reasons for initiation and discontinuation of hormone replacement therapy. Menopause. 6:1999;282-289.
17. Hill D.A., Weiss N.S., LaCroix A.Z. Adherence to postmenopausal hormone therapy during the year after the initial prescription: a population-based study. Am. J. Obstet. Gynecol. 182:2000;270-276.
18. Staland B. Continuous treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation. Maturitas. 3:1983;145-156.
19. Egarter Ch., Huber J., Leikermoser R., Haidbauer R., Pusch H., Fischl F., et al. Tibolone versus conjugated estrogens and sequential progestogen in the treatment of climacteric complaints. Maturitas. 23:1996;55-62.
20. Belaisch J., Nappi C., Affinito P., De Gezelle H., Botelho M., Oliveira H.M., et al. Effets sur les lipides, les symptômes climatériques et l'endomètre d'une association d'estrogénes conjugués et de médrogestone dans le traitement hormonal substitutif. J. Gynecol. Obstet. Biol. Reprod. 29:2000;29-40.